Generalized Anxiety Disorder
📧 Sign up to get email alerts when something new happens for Generalized Anxiety Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2024-10-25FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Quallent Pharmaceuticals Health LLC)
The FDA approved a supplemental application for escitalopram oxalate from Quallent Pharmaceuticals Health LLC, a generic antidepressant.
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: Efficacy and Safety of Inhaled NC-107 As Compared to Placebo After 4 Weeks of Treatment in Patients with Anxiety [EARLY_Phase 1]
This early Phase 1 trial compares inhaled NC-107 to placebo for 4 weeks in patients with Generalized Anxiety Disorder, assessing efficacy an…
-
CLINICAL_TRIALS research · 2024-10-24Clinical Trial Update: BreathinG-induced Myocardial and Cerebral Perfusion in Anxiety Disorders
A clinical trial update indicates that recruitment is ongoing for a study evaluating breath-induced myocardial and cerebral perfusion in Gen…
-
CLINICAL_TRIALS trial_result · 2024-10-18Clinical Trial Update: Comparing the Efficacy of E-CBT to Mental Health Coaching for GAD [NA]
A completed clinical trial comparing electronic cognitive behavioral therapy (E-CBT) to mental health coaching for generalized anxiety disor…
-
FDA approval · 2024-10-17FDA Approved: CLORAZEPATE DIPOTASSIUM — Supplemental Application (NORTHSTAR RX LLC)
FDA approved a supplemental application for clorazepate dipotassium submitted by NorthStar RX LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-10-08FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for escitalopram oxalate (escitalopram) submitted by Exelan Pharmaceuticals Inc.
-
FDA approval · 2024-10-07FDA Approved: ESCITALOPRAM — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for escitalopram oxalate from Aurobindo Pharma Limited, enabling this generic product to be mark…
-
FDA approval · 2024-10-07FDA Approved: ESCITALOPRAM — Supplemental Application (Accord Healthcare Inc.)
FDA approved a supplemental application for escitalopram by Accord Healthcare Inc., finalizing a change to a generic escitalopram product.
-
FDA approval · 2024-10-02FDA Approved: ESCITALOPRAM OXALATE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for escitalopram oxalate submitted by Amneal Pharmaceuticals LLC.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Effects of rTMS on the Anxiety State of Older Patients With GAD [NA]
A clinical trial update describing a study on the effects of repetitive transcranial magnetic stimulation (rTMS) on anxiety in older adults …
-
CLINICAL_TRIALS research · 2024-09-25Clinical Trial Update: Anxiety is One of the Most Frequent Disorders During the Perinatal Stage Which is Associated with Adverse Health Effects for Women and Their Babies. This Study Will Be to Evaluate the Effectiveness of a Telematic Cognitive-behavioral Preventive Intervention to Manage Anxiety During Pregnancy. [NA]
A clinical trial is evaluating the effectiveness of a telematic cognitive-behavioral preventive intervention to manage anxiety during pregna…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Pivotal RCT to Test Safety and Efficacy of Digital Therapeutics 'ANZEILAX' for Managing Generalized Anxiety Disorder [NA]
A pivotal randomized trial evaluating the safety and efficacy of the digital therapeutic ANZEILAX for Generalized Anxiety Disorder has compl…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Meditation and Kundalini Yoga for Heightened Anxiety Related to COVID-19 [NA]
A completed clinical trial evaluated meditation and Kundalini Yoga for COVID-19–related anxiety, and results have been posted.
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: The Effectiveness of Transdiagnostic CBT Protocol on Anxiety Disorders [NA]
Clinical trial from Ibn Haldun University evaluating a transdiagnostic CBT protocol for anxiety disorders, including social anxiety disorder…
-
FDA approval · 2024-08-29FDA Approved: PAROXETINE — Supplemental Application (Modavar Pharmaceuticals LLC)
The FDA approved a supplemental application for paroxetine from Modavar Pharmaceuticals LLC.
-
FDA approval · 2024-08-28FDA Approved: PREGABALIN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for pregabalin.
-
FDA approval · 2024-08-23FDA Approved: PREGABALIN — Supplemental Application (Solco Healthcare US, LLC)
FDA approved a supplemental application for pregabalin from Solco Healthcare US, LLC, granting approval for changes related to the generic p…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: A Transdiagnostic, Self-guided Internet Intervention ("Velibra") for Waitlist Patients With Anxiety Disorders [NA]
A clinical trial update for Velibra, a transdiagnostic, self-guided internet intervention for waitlist patients with anxiety disorders, curr…
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: CBT for Anxiety Sensitivity vs. Disorder-specific CBT: An RCT [NA]
A randomized trial comparing CBT that targets anxiety sensitivity with disorder-specific CBT has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-13Clinical Trial Update: Friendship Bench Adaptation to Improve Mental Health & HIV Care Engagement Outcomes Among PLWH and PWID in Vietnam [NA]
The study completed and results were posted for a Friendship Bench adaptation designed to improve mental health outcomes and HIV care engage…
-
FDA approval · 2024-08-12FDA Approved: VENLAFAXINE — Supplemental Application (Ascend Laboratories, LLC)
The FDA approved a supplemental application for venlafaxine submitted by Ascend Laboratories, LLC.
-
CLINICAL_TRIALS research · 2024-08-12Clinical Trial Update: Better Sleep in Psychiatric Care - Depression, Anxiety and PTSD [NA]
An update on a Karolinska Institutet clinical trial evaluating sleep interventions in psychiatric care, focusing on depression, anxiety diso…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Patient-centered Treatment of Anxiety After Low-Risk Chest Pain in the Emergency Room [NA]
An update on a clinical trial led by Indiana University evaluating patient-centered treatment for anxiety after low-risk chest pain in the e…
-
FDA approval · 2024-07-26FDA Approved: BUSPIRONE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for buspirone hydrochloride from Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS trial_result · 2024-07-22Clinical Trial Update: Outcomes of a Self-guided Versus Therapist-guided Online Mental Health Treatment [NA]
A completed clinical trial by Duke University comparing self-guided versus therapist-guided online treatment for depression and anxiety, rep…